Shutterstock_772350676
September 19, 2022

Aflibercept 8mg Extended Injection Interval Set to Reduce Treatment Burden for nAMD and DME

Not only is neovascular (wet) age-related macular degeneration (nAMD) one of the leading causes of vision impairment around the world,…

shutterstock_431522512_800
September 15, 2022

Lowering Treatment Burden and Maintaining Vision Gains with Aflibercept

The introduction of anti-vascular endothelial growth factor (anti-VEGF) therapy revolutionized the management and treatment of exudative retinal diseases — and…

Discover our fascinating content at issuu

explore